Loading…
Reliance Chemotex Industries (RELCHEMQ)₹127.29−1.74%Other Textile Products
In the Jun 2026 quarter (standalone), Reliance Chemotex Industries reported sales of ₹99.01 Cr, up 7.0% from Jun 2025, and net profit of ₹1.38 Cr, up 29.0% year on year. For the year to Mar 2026, sales were ₹363 Cr and net profit ₹5.01 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 89.58 | 85.73 | 102 | 92.81 | 91.84 | 92.39 | 82.38 | 92.49 | 99.70 | 82.14 | 88.33 | 99.01 |
| Expenses | 82.33 | 78.02 | 94.51 | 86.67 | 85.45 | 83.11 | 70.72 | 81.57 | 89.12 | 71.15 | 79.12 | 87.93 |
| Operating Profit | 6.96 | 7.43 | 7.72 | 5.86 | 6.10 | 8.99 | 11.38 | 10.78 | 10.30 | 10.73 | 8.99 | 10.82 |
| OPM % | 7.7% | 8.7% | 7.5% | 6.3% | 6.6% | 9.7% | 13.7% | 11.6% | 10.3% | 13.0% | 10.1% | 10.9% |
| Other Income | 0.80 | 0.94 | 1.42 | 4.12 | 3.74 | 0.55 | 1.71 | 0.38 | 0.35 | 0.39 | 2.67 | 0.89 |
| Interest | 4.80 | 4.93 | 5.07 | 6.35 | 6.02 | 5.90 | 5.84 | 6.49 | 5.87 | 6.31 | 6.20 | 6.75 |
| Depreciation | 2.51 | 2.52 | 2.55 | 3.45 | 3.47 | 3.49 | 4.21 | 3.68 | 3.69 | 3.69 | 3.69 | 3.62 |
| Profit before tax | 0.41 | 0.90 | 1.48 | 0.17 | 0.32 | 0.11 | 3.02 | 0.95 | 1.05 | 1.07 | 1.73 | 1.29 |
| Tax % | −9.6% | 92.2% | 69.1% | −233.4% | −327.3% | −58.4% | 38.9% | −11.5% | −55.7% | 25.9% | −0.6% | −5.4% |
| Net Profit | 0.47 | 0.07 | 0.47 | 0.60 | 1.43 | 0.20 | 1.85 | 1.07 | 1.66 | 0.81 | 1.76 | 1.38 |
| EPS (Rs) | 0.62 | 0.09 | 0.62 | 0.79 | 1.89 | 0.26 | 2.45 | 1.42 | 2.20 | 1.07 | 2.33 | 1.83 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258 | 292 | 286 | 324 | 301 | 257 | 363 | 365 | 367 | 358 | 363 | 369 |
| Expenses | 238 | 269 | 265 | 298 | 271 | 232 | 317 | 329 | 335 | 324 | 321 | 327 |
| Operating Profit | 19.05 | 22.04 | 19.04 | 26.06 | 28.08 | 23.07 | 45.12 | 35.10 | 31.07 | 32.07 | 41.08 | 40.84 |
| OPM % | 7.0% | 8.0% | 7.0% | 7.9% | 9.0% | 9.0% | 11.9% | 9.9% | 8.0% | 8.9% | 11.0% | 11.1% |
| Other Income | 2.99 | 3.99 | 0.99 | 1.99 | 0.99 | 3.99 | 2.99 | 5.99 | 3.99 | 9.99 | 3.99 | 4.30 |
| Interest | 13.01 | 14.01 | 11.99 | 13.01 | 11.01 | 9.99 | 11.99 | 13.99 | 19.98 | 24.01 | 24.99 | 25.13 |
| Depreciation | 6.99 | 6.99 | 6.98 | 6.98 | 6.99 | 7.98 | 8.98 | 9.98 | 9.97 | 14.96 | 14.96 | 14.69 |
| Profit before tax | 1.99 | 4.99 | 0.99 | 7.99 | 10.98 | 9.99 | 26.95 | 16.97 | 5.99 | 3.99 | 4.99 | 5.14 |
| Tax % | −48.1% | −35.1% | −217.1% | 48.9% | 13.0% | 33.0% | 33.9% | 26.0% | 42.9% | −11.0% | −9.1% | — |
| Exceptional items | 0.03 | 0.11 | 0.00 | 0.00 | 0.05 | −0.11 | −2.49 | −0.33 | 0.00 | 0.03 | 0.00 | — |
| Net Profit | 3.01 | 6.02 | 3.01 | 4.01 | 9.04 | 7.02 | 18.05 | 12.03 | 3.01 | 4.01 | 5.01 | 5.61 |
| EPS (Rs) | 3.17 | 8.12 | 3.26 | 5.12 | 12.39 | 9.21 | 24.09 | 16.49 | 4.27 | 5.38 | 6.98 | 7.43 |
| Dividend payout % | 16.0% | 6.0% | 15.0% | 15.0% | 8.0% | 22.0% | 10.0% | 15.0% | 24.0% | 9.0% | 7.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | 8.03 | 8.02 |
| Reserves | 31.96 | 32.01 | 64.01 | 65.91 | 62.96 | 90.97 | 96.95 | 114 | 124 | 126 | 130 | 135 |
| Borrowings | 107 | 113 | 94.69 | 93.65 | 81.79 | 64.84 | 96.68 | 127 | 198 | 280 | 262 | 267 |
| Other Liabilities | 48.14 | 52.91 | 63.89 | 63.12 | 68.81 | 64.80 | 60.77 | 84.09 | 65.95 | 66.27 | 74.25 | 102 |
| Total Liabilities | 191 | 201 | 227 | 228 | 218 | 227 | 262 | 333 | 396 | 480 | 473 | 511 |
| Fixed Assets | 107 | 109 | 152 | 145 | 140 | 136 | 147 | 181 | 195 | 317 | 312 | 298 |
| CWIP | 1.99 | 0.99 | 0.00 | 0.00 | 0.00 | 5.98 | 0.99 | 9.96 | 38.91 | 0.99 | 0.00 | 0.00 |
| Investments | 2.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 79.08 | 90.98 | 76.06 | 82.03 | 79.04 | 84.96 | 113 | 142 | 162 | 163 | 162 | 213 |
| Inventories | 33.92 | 38.86 | 37.91 | 40.86 | 37.89 | 34.92 | 46.88 | 43.86 | 44.88 | 53.82 | 68.76 | 98.71 |
| Trade receivables | 13.02 | 21.06 | 18.04 | 17.04 | 18.05 | 13.03 | 11.03 | 5.02 | 7.01 | 6.01 | 18.04 | 10.02 |
| Cash & equivalents | 3.99 | 4.99 | 4.99 | 3.99 | 3.99 | 4.99 | 32.92 | 57.81 | 61.85 | 50.86 | 10.97 | 12.97 |
| Total Assets | 191 | 201 | 227 | 228 | 218 | 227 | 262 | 333 | 396 | 480 | 473 | 511 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.00 | 12.03 | 32.04 | 11.03 | 26.03 | 22.06 | 27.04 | 59.11 | 0.00 | 18.03 | 11.02 | 22.04 |
| Cash from investing activity | −27.10 | −6.03 | −2.01 | 0.00 | 0.00 | −8.03 | −43.18 | −74.23 | −51.21 | −82.35 | 33.10 | −2.01 |
| Cash from financing activity | 28.05 | −6.01 | −30.03 | −11.01 | −26.01 | −13.01 | 15.02 | 14.02 | 55.04 | 60.07 | −43.05 | −20.01 |
| Net cash flow | 0.99 | 0.00 | 0.00 | −0.99 | 0.00 | 0.99 | 0.00 | 0.00 | 3.99 | −3.99 | 0.00 | 0.00 |
| Capex | 30.32 | 7.57 | 3.64 | 1.20 | 0.85 | 6.98 | 16.06 | 52.06 | 54.58 | 92.62 | 9.02 | 0.79 |
| Free cash flow | −28.95 | 4.99 | 27.93 | 9.97 | 24.94 | 14.97 | 11.98 | 8.97 | −53.92 | −74.78 | 1.99 | 20.96 |
| CFO / OP % | 17.9% | 68.0% | 152.0% | 62.0% | 105.0% | 83.0% | 118.0% | 140.0% | 7.0% | 62.0% | 32.0% | 54.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 21 | 30 | 23 | 22 | 20 | 16 | 15 | 5 | 7 | 6 | 18 | 10 |
| Inventory days | 93 | 102 | 85 | 97 | 74 | 82 | 138 | 91 | 87 | 104 | 145 | 224 |
| Days payable | 71 | 85 | 80 | 85 | 71 | 66 | 59 | 58 | 29 | 33 | 59 | 56 |
| Cash conversion cycle | 43 | 47 | 29 | 35 | 23 | 32 | 94 | 39 | 66 | 77 | 104 | 178 |
| Working capital days | 21 | 0 | −19 | −22 | −11 | −12 | −42 | −62 | −81 | −58 | −27 | −1 |
| ROCE % | 16.0% | 10.0% | 12.0% | 8.0% | 13.1% | 14.1% | 11.1% | 19.1% | 11.0% | 7.0% | 7.0% | 7.0% |
For the Jun 2026 quarter, Reliance Chemotex Industries reported sales of ₹99.01 Cr, up 7.0% year on year and net profit of ₹1.38 Cr, up 29.0% year on year. The operating margin was 10.9%.
Reliance Chemotex Industries' sales for the year to Mar 2026 were ₹363 Cr; over the last twelve months they were ₹369 Cr.
Net profit for the year to Mar 2026 was ₹5.01 Cr, and ₹5.61 Cr over the last twelve months. Earnings per share over the same trailing period were ₹7.43.
Reliance Chemotex Industries reported borrowings of ₹267 Cr at Mar 2026, against cash and equivalents of ₹12.97 Cr.
Cash from operations was ₹22.04 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹20.96 Cr.